Consumer Feels Like...
Health Care: Drugs
Biovail Corporation International (BVF: NYSE)
$26.35 -0.76 | -2.80%
09/27/10 - 04:01 PM ET
14.82M / 3.29M
Vol / Avg. Vol:27.22 / 27.11
Open / Prev. Close:26.30 - 27.53
Today's Range:12.91 - 27.74
52 Wk Range:88.75%
Performance YTD:TheStreet Rating:
Portfolios with BVF
- Portfolio NameUser Type
- Usertundra
- ProFidelity Select Pharmaceuti...
- ContributorBarron's Activist Stocks 3-...
- UserPART 5 JPMorgan 28th Annual...
- UserTimbotim2 Portfolio 1
- ContributorBarron's Activist Stocks 3-...
- UserStocks to Help You Survive ...
- UserDividend Blend
- UserMagic Formula 121508
- ContributorHigh Cash, No Debt, High Yi...
Latest BVF Headlines from TheStreet
- Today's Outrage: Skeptics Missing at SEC 03.30.11 | 07:03 am
- Valeant Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript 11.07.10 | 10:11 pm
- Dividend Hikes: Microsoft 09.22.10 | 09:09 am
- Biovail Corp Q2 2010 Earnings Call Transcript 08.05.10 | 01:08 pm
- Navarro's High Volume Movers
06.23.10 | 09:06 am - Sonic, Walgreen, Patriot Coal Are Big Movers 06.22.10 | 06:06 pm
- NYSE Stocks Posting Largest Percentage Increases 06.22.10 | 05:06 pm
- Bulls Get Lift From China's Yuan Announcement 06.21.10 | 05:06 am
- Biovail, Valeant Agree to Merge 06.21.10 | 03:06 am
- Biovail Corp. Q1 2010 Earnings Call Transcript 05.06.10 | 05:05 pm
Press Releases for BVF
- Valeant And Biovail Announce Results Of Special Meetings Of Shareholders - Business Wire 09.27.10 | 02:09 pm
- Valeant And Biovail Announce Valeant’s Intention To Declare A Special Dividend To Valeant Stockholders Upon Obtaining Shareholder Approval, Financing And Satisfaction Of Other Closing Conditions - Business Wire 09.22.10 | 08:09 am
- Valeant And Biovail Set Date For Shareholders Meetings - Business Wire 08.11.10 | 07:08 am
- Biovail Reports Second-Quarter 2010 Financial Results - Business Wire 08.05.10 | 07:08 am
- Biovail Declares Quarterly Dividend - Business Wire 08.05.10 | 06:08 am
- Biovail Announces Second-Quarter 2010 Earnings Release, Conference-Call Details - Business Wire 07.23.10 | 12:07 pm
- Biovail And MedGenesis Announce Grant From The Michael J. Fox Foundation For The Development Of GDNF - Business Wire 06.22.10 | 04:06 pm
- Robbins Umeda LLP Announces An Investigation Of The Acquisition Of Valeant Pharmaceuticals International By Biovail Corporation - Business Wire 06.21.10 | 05:06 pm
- Valeant And Biovail Agree To Merge - Business Wire 06.21.10 | 02:06 am
- Biovail Enters Into License Agreement With Kyowa Hakko Kirin - Business Wire 06.03.10 | 04:06 am
Partner Headlines for BVF
- Biovail Backpedals From Allegations, Again - Seeking Alpha 11.07.10 | 08:11 am
- Thursday Options Update: AMAG, BID, ERIC, BAX, NVDA, VIT, BVF, ETFC - Seeking Alpha 09.24.10 | 03:09 pm
- Thursday Options Brief: NVDA, VIT, BVF, ETFC - Seeking Alpha 09.24.10 | 01:09 pm
- Valeant Pharmaceuticals Rallying On Job Cuts (VRX) - Benzinga 09.07.10 | 09:09 am
- Biovail Rallying On UBS Target Increase (BVF) - Benzinga 09.07.10 | 09:09 am
- WRAPUP 3-Biovail, Paladin profits beat estimates - Reuters 08.05.10 | 05:08 pm
- Jefferies Places Valeant Pharma on Their Restricted List (VRX) - Benzinga 08.04.10 | 09:08 am
- Piper Jaffray Upgrades Biovail to Overweight (BVF) - Benzinga 07.16.10 | 09:07 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 07.16.10 | 09:07 am
- Biovail Corp. (BVF) bearishness crosses tape due to buying - ONN.TV 07.02.10 | 05:07 pm
